Sugi Predict

Sugi Predict / Compounds / SCHEMBL3602387

SCHEMBL3602387

SCHEMBL3602387

COC(=O)CCCCC(CCc1ccccc1OCc1ccc(C2CCCCC2)cc1)Oc1ccc(C(=O)OC)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ PTGER1 P34995 1/20 0.36
▸ PTGER4 P35408 1/20 0.36
▸ PTGER3 P43115 1/20 0.36
▸ PTGER2 P43116 1/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.35
▸ FFAR4 Q5NUL3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3600414 0.86 RAB9A (0.37) MAPTRAB9ALMNAL3MBTL1TP53
SCHEMBL3596961 0.86 PTGER1 (0.47) HPGDPTGER1PTGER4PTGER3PTGER2
SCHEMBL3604761 0.85 MAPT (0.36) MAPTRAB9ALMNAL3MBTL1TP53
SCHEMBL6002376 0.85 NPSR1 (0.44) MAPTRAB9ALMNAL3MBTL1TP53
SCHEMBL3598271 0.85 PDE4A (0.39) MAPTRAB9ALMNAL3MBTL1TP53
SCHEMBL3603564 0.84 KMT2A (0.36) MAPTRAB9ALMNAL3MBTL1TP53
SCHEMBL13443165 0.84 PTGFR (0.40) PTGER1PTGER4PTGER3PTGER2POLB
SCHEMBL3591301 0.83 PTGER1 (0.37) ALDH1A1PTGER1PTGER4PTGER3PTGER2
SCHEMBL13443487 0.82 PPARG (0.40) MAPTRAB9ALMNAL3MBTL1TP53
SCHEMBL13009721 0.81 BCHE (0.38) MAPTRAB9ALMNAL3MBTL1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674825-B2 Dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2010-03-09 — — US disclosed
US-7674825-B2 Dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2010-03-09 — — US disclosed
US-7674825-B2 Dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2010-03-09 — — US disclosed
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT 2008-03-06 — — US disclosed
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT 2008-03-06 — — US disclosed
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT 2008-03-06 — — US disclosed
EP-1216223-B1 NOVEL DICARBOXYLIC ACID DERIVATIVES WITH PHARMACEUTICAL PROPERTIES BAYER HEALTHCARE AG (DE) 2005-11-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties PC, GOT2, SDHA MAPT 2293/4885RAB9A 3540/4885LMNA 2227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.